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Objective: Impaired physical function is a feature of patients with peripheral arterial disease (PAD) who present with
symptoms of intermittent claudication (PAD-IC). Previous research found that temporal-spatial gait parameters do not
discriminate between PAD-IC patients and control subjects during normal and maximal walking even though PAD-IC
patients have decreased physical function characteristic of the disease. This study examined the hypothesis that patients
with PAD-IC would demonstrate decreased temporal-spatial gait parameters, gait kinematics, walking performance,
physiologic responses to exercise, and physical activity level compared with control subjects. The aim was to examine the
temporal-spatial gait parameters and gait kinematics of individuals with PAD-IC and to determine the relationship
between these variables and walking performance, exercise capacity, and physical activity level in these individuals.
Method: A cross-sectional study of 28 PAD-IC subjects (IC) and 25 controls (CON) matched for age and mass was
conducted in a medical faculty human performance laboratory. IC subjects had a history of PAD, ankle-brachial pressure
index (ABI) <0.9 in at least one leg, and a positive Edinburgh Claudication Questionnaire response. Gait characteristics
were determined by two-dimensional motion analysis. A graded treadmill test was used to assess walking performance and
peak physiologic responses to exercise. Physical activity levels were measured by analysis of 7-day pedometer recording
motion. Differences between groups were examined by one-way analysis of covariance.
Results: Compared with CON, IC temporal-spatial gait parameters were significantly lower (P < .05), except for single
support ipsilateral limb time. IC subjects spent a greater percentage of time in gait support phases, took longer to
complete a stride, and had reduced stride length and walking speeds during the gait cycle. IC joint angular kinematics
showed significantly reduced displacement of ankle plantar flexion (P .017), knee range of motion (P .021), and hip
extension (P  .016) compared with the CON subjects during the gait cycle. All joint minimum and maximum angular
velocities and accelerations, walking physiologic responses, and physical activity levels were significantly lower for IC
compared with the CON subjects.
Conclusion: IC subjects walk with a shuffling gait pattern indicated by reduced joint angular displacement, velocities, and
accelerations that results in reduced walking performance and physiologic responses and physical activity compared with
controls matched for age, mass, and physical activity. ( J Vasc Surg 2007;45:1172-8.)Peripheral arterial disease (PAD) is a chronic arterial oc-
clusive disease of the lower extremities caused by atheroscle-
rosis.1 The most common presenting symptom of PAD is
intermittent claudication (PAD-IC), with exercise-induced
pain experienced in the calves, thighs, or buttocks that is
relieved with rest.2-4 However, many patients with significant
PAD do not report or complain of IC pain.5
Compared with healthy age matched controls, patients
with PAD-IC demonstrate reduced physiologic capacity;
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1172lower limb mobility, walking performance, and physical
activity levels; and decreased health-related quality of
life.6,7 Decreased lower limb mobility results in reduced
temporal-spatial gait parameters such as stride length and
speed.8
The research on temporal-spatial gait parameters in
PAD-IC patients while free of claudication pain is inconsis-
tent. Some research has determined that PAD-IC individ-
uals walk slower, and have slower cadence rates and smaller
stride lengths due to an increase in double limb support and
stride time,9,10 whereas other studies have indicated no
effect on temporal-spatial gait parameters.11-13 Although
the research focus has been on temporal-spatial gait param-
eters, to our knowledge, no studies to date have examined
the underlying mechanism of these parameters; namely,
gait kinematics, including lower limb joint angular veloci-
ties, accelerations, and displacements. Observed limitations
in temporal-spatial gait parameters may be explained by the
effects of musculoskeletal abnormalities (eg, compromised
blood and nerve supply, injury) on lower limb joint kine-
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ics of affected gait parameters allows more precise identifi-
cation of the etiology of the abnormality and its effects at
the joint-muscle interface, which in turn allows for more
precise formulation of exercise rehabilitation treatment
plans.14
The aim of this study was to examine the temporal-
spatial gait parameters and gait kinematics of individuals
with PAD-IC and the relationship between gait kinemat-
ics, walking performance, exercise capacity, and physical
activity level in this population. We hypothesized that
individuals with PAD-IC would demonstrate decreased
temporal-spatial gait parameters, gait kinematics, walk-
ing performance, physiologic responses to exercise, and
physical activity level compared with healthy controls
matched for age and mass.
METHODS
Subjects. Subjects (n  28) presenting with PAD-IC
(IC) were selected based on an appropriate history demon-
strating occlusive PAD with absence of significant periph-
eral neuropathy and physical examination by a consultant
vascular physician. PAD-IC was confirmed by absence of
peripheral pulses, imaging-confirmed lower limb artery ste-
nosis or occlusion, ankle-brachial pressure (ABI) index
0.9 and a positive EdinburghClaudicationQuestionnaire
response.15 Details of each subject’s medical history and
medications were recorded, as previously described.16 A
further group of 25 subjects free of PAD (ABI 0.9) who
did not exercise regularly were recruited from the commu-
nity by e-mail bulletin boards and local newspaper and
television coverage to act controls (CON) matched for age
and mass. Subjects were excluded from the study if they
required mobility aids, had observable gait abnormalities
(eg, Steppage, vaulting, circumduction, and hip hiking) or
medical conditions that influenced gait (eg, orthopedic
conditions and neurologic impairment). Comorbidity and
smoking history was determined by questionnaire. All sub-
jects volunteered and gave written informed consent to
participate in this study as approved by the James Cook
University Human Research Ethics Committee.
All testing was conducted in the Human Performance
Laboratory, Institute of Sport and Exercise Science, James
Cook University, Townsville campus. Subjects were as-
sessed in the laboratory early in themorning after a 12-hour
fast. After completing informed consent and study infor-
mation procedures, they underwent ABI measurement,
body composition, gait, and exercise performance testing.
Ankle-brachial index. ABI measurements were taken
by a qualified sonographer using a handheld bidirectional
Doppler instrument (MD6, Hokanson, Bellevue, Wash)
with a 5-MHz transducer and standard blood pressure cuffs
after the subject had rested supine for 10 minutes . Systolic
blood pressure was measured at the ankle (taking the
highest of either the dorsalis pedis or posterior tibial arter-
ies). That value was divided by the systolic blood pressure in
the brachial artery (taking the highest of either the left or
right arm arteries).17Anthropometry. Subject height was determined by a
wall mounted telescopic metal stadiometer (Seca 220, Seca
Scales, Hamburg, Germany). Body mass and composition
(% body fat) were determined by bioelectrical impedance
scales (TANITA TBF 521, TANITA Corp, Arlington
Heights, Ill). Body mass index (BMI) was calculated as
kg/m2.
Gait. Major joint segments were identified using re-
flective markers placed on five landmarks on the ipsilateral
(right side) of the subject’s body. The landmarks were
determined by palpation, and the reflective markers were
positioned at the shoulder (acromion), hip (greater tro-
chanter of femur), knee (lateral epicondyle of femur), ankle
(lateral malleolus of fibula), and head of the fifthmetatarsal.
Subjects were instructed to walk normally without
shoes along a 10-m walkway that was marked at 1-cm
intervals whilst the subject was in a pain free state. Digital
imagery was obtained with a high-speed digital video cam-
era (Canon MV550i, Canon Australia, North Ryde, Aus-
tralia) set at a frame rate of 50 Hz and placed 3 m perpen-
dicular to the line of motion, providing an uninterrupted
video field.
Five complete trials were achieved. A walking trial was
deemed to be complete and suitable for analysis if all
anatomic markers were visible at the first and last ipsilateral
heel strike. Three walking trials (one stride per trial) were
then randomly selected for kinematic analysis.18 After the
recording of video footage, digital images were captured by
a video capture card (Adaptec FireConnect for Notebooks,
Adaptec Inc, Milpitas, Calif) and appropriate joints were
identified and named with digitizing software (Silicon-
Coach Ltd, Dunedin, New Zealand) operating on a laptop
computer (Toshiba PIV, Toshiba Australia, North Ryde,
Australia).
Two markers were placed 1 m apart on the floor in the
direction of travel to calibrate the digitizing software. The
first author performed all digitizing of the digital video
images to prevent intraindividual variability in anatomic
marker identification. The intraclass correlation coefficient
values for the digitized X and Y coordinate data ranged
from 0.9 to 0.95. The intraclass correlation coefficient data
for within-subject gait kinematic measures was 0.8 to 0.85.
Data points were used to calculate gait kinematic pa-
rameters, including peak displacements, velocities, and ac-
celeration for the ipsilateral lower limb joints. Fig 1 outlines
the joint angle conventions used to determine the kine-
matic variables. Graphic representations of the angular
kinematics of the trunk, hip, knee, and ankle joints were
normalized (100 points) for the gait cycle using a cubic
spline routine to determine a mean ensemble curve and
95% confidence intervals.19 Temporal-spatial gait parame-
ters determined were stride length, stride cadence, contact
time, flight time, initial double support time, ipsilateral leg
support time, final double support time, contralateral leg
support time, total time, and speed. For the purpose of this
study, stride length was calculated as the distance from
successive initial ground contacts of the ipsilateral foot.
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lected, subjects undertook a graded exercise test on a
treadmill (Trackmaster TMX55, Full Vision, Newton, Kan)
for determination of walking performance and physiologic
responses to exercise. The physiologic responses obtained
at peak exercise included oxygen uptake (VO2peak), respi-
ratory exchange ratio (RERpeak), ventilation (VEpeak), and
heart rate (HRpeak). The physiologic responses were deter-
Fig 1. Joint angle conventions.mined by indirect calorimetry using a metabolic cart(Power lab/8M Metabolic system, ADInstruments Pty
Ltd, Castle Hill, Australia). The metabolic gas analysis
system was switched on 30 minutes before each test and
calibrated using a 3 liter syringe, temperature (°C), baro-
metric pressure (mm Hg), airflow (L), body mass (kg),
room air (20.93% and 0.04% for O2 and CO2 respectively)
and alpha gas composition (about 10% O2, about 7% CO2;
BOC, Melbourne, Australia).
Before the test began, the subject was fitted with a
headpiece that held a rubber mouthpiece connected to a
T-shaped two-way nonrebreathing value (Hans Rudolph,
Inc, Kansas City, Mo), which in turn was connected to the
mixing chamber of the metabolic gas analysis system by
35-mm-diameter smooth-bore hosing.
Electrocardiograph (ECG) electrodes (silver/silver
chloride electrodes, 3M, Pymble, Australia) were posi-
tioned at the manubrium, seventh cervical vertebra, and
fifth intercostal-axiliary line (lead II) for an ECG recording.
All physiologic responses were recorded continuously using
Chart 5.1 (ADInstruments Pty Ltd, Castle Hill, Australia)
sampling at 1000 Hz and were analyzed post-test as 15-
second averages.
The graded treadmill walking protocol consisted of a
constant speed of 3.2 km/h and an incline of 0% for the first
2 minutes, which was increased by 2% every 2 minutes.20
Subject perception of exercise intensity was determined
every 60 seconds by Borg’s21 Rating of Perceived Exertion
(RPE) instrument, and the subject’s perception of the
distance to onset, moderate, intense, and maximal claudi-
cation pain was determined by the 5-point Claudication
Pain Scale: 0  no pain, 1  onset of pain, 2  moderate
Table I. Descriptive characteristics of intermittent
claudication subjects and healthy controls matched for





(n  25) P
Age (year) 69.9  1.5 66.2  1.5 .642
Height (cm) 166.3  1.6 167.6  1.5 .678
Mass (kg) 79.3  3.1 74.6  2.4 .224
Body fat (%) 32.2  1.6 33.6  1.5 .550
BMI 28.5  0.9 26.5  0.7 .095
ABI left leg 0.73  0.05 1.16  0.03 .001†
ABI right leg 0.71  0.04 1.16  0.03 .001†
Gender (male) 50 40 .333
Current smoker 25 0 .007
Former smoker 64 32 .001†
Type II diabetes 25 0 .007
Hypertension 43 24 .154
Ischemic heart disease 35.7 0 .001†
Arthritis 18 16 .861
-Blocker Rx 28.6 0 .001†
IC, Intermittent claudication; CON, control; ABI, ankle-brachial index;
BMI, body mass index.
*Continuous variables are presented as mean  standard error, or as a
percentage.
†P  .001 vs peripheral arterial disease-intermittent claudication.pain, 3  intense pain, 4  maximal pain.22
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sessed by the distance walked until perceived maximal
claudication pain, exhaustion, or until 25 minutes of walk-
ing was achieved. Subjects were permitted to hold the
treadmill handrail if they required support whilst walking,
and a number of common phrases (eg, you canmake it, keep
walking) were used to encourage subjects, and their use was
Table II. Temporal-spatial gait parameters of
intermittent claudication subjects and healthy controls





(n  25) P
Stride length (m) 1.20  0.03 1.35  0.03 .001
Cadence (steps/min) 106.9  1.4 115.1  1.1 .001†
Stride time (s) 1.13  0.02 1.05  0.01 .001†
Contact time (s) 0.70  0.01 0.65  0.01 .001†
Flight time (s) 0.43  0.01 0.40  0.01 .004
Single support (s)
Contralateral 0.43  0.01 0.40  0.01 .004
Ipsilateral 0.41  0.01 0.40  0.01 .077
Double support (s)
1 0.15  0.01 0.13  0.01 .001
2 0.14  0.01 0.12  0.01 .025
Speed (m/s) 1.08  0.03 1.30  0.03 .001†
Stride length, Distance either foot moves during the gait cycle; Cadence,
number of steps taken in a minute; Stride time, time taken to produce a
stride;Contact time, time that the ipsilateral foot is in contact with the floor;
Flight time, time that the ipsilateral foot is not in contact with the floor;
Single support, time that each foot is spent in contact with the floor by itself;
Double support, time that is spent with both feet on the floor; Speed,
calculation of stride length and stride time.
*Values are presented as mean  standard error of the mean.
†P  .001 vs peripheral arterial disease-intermittent claudication.
Table III. Peak and range of motion angular kinematics
of intermittent claudication subjects and healthy controls





(n  25) P
Ankle
ROM 22.31  0.59 24.28  0.92 .151
Plantar flexion –10.03  0.43 –12.52  0.95 .036†
Dorsiflexion 12.21  0.65 11.75  0.60 .570
Knee
ROM 56.84  1.22 60.29  0.70 .048†
Flexion 57.56  1.05 59.19  0.66 .365
Extension 0.69  0.82 –1.14  0.49 .072
Hip
ROM 33.53  1.08 36.03  1.02 .081
Flexion 21.00  0.96 19.55  0.96 .459
Extension –12.67  1.01 –16.49  1.16 .027†
Trunk
ROM 8.17  0.38 9.12  0.47 .235
Flexion 3.37  0.54 2.66  0.67 .591
Extension –4.80  0.53 –6.46  0.67 .157
IC, Intermittent claudication; CON, control; ROM, range of motion.
*Values are mean  standard error of the mean.
†P  .05 vs peripheral arterial disease-intermittent claudication.standardized by noting the frequency and type of phraseFig 2. Trunk, hip, knee, and ankle kinematics in the sagittal plane
for intermittent claudication (IC) and control (CON) subjects.
The dashed line indicates toe-off at about 60% gait cycle, with 0% to
60% representing stance; 60% to 100% representing swing.
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tion criteria included voluntary exhaustion, claudication
pain, or abnormal ECG rhythm.
Physical activity level. After laboratory testing, sub-
jects’ daily physical activity levels as measured by number of
steps, distance walked, and calories expended during walk-
ing were determined from recordings from a 7-day pedom-
eter (YAMAX DigiWalker SW-700, YAMAX Corp, Tokyo,
Japan).
Statistical analyses. Statistical analysis was performed
using SPSS 14 (SPSS Inc, Chicago, Ill) software for Win-
dows (Microsoft Corp, Redmond, Wash). Descriptive sta-
tistics were expressed as mean  standard deviation. Box-
plot analyses were performed to identify extreme and
outlier data. Data were analyzed using one-way analysis of
covariance with one between-subjects factor (PAD-IC vs
CON) and age as covariate.23 An  level of .05 was adopted
for this study.
RESULTS
Subjects. Subjects in both groups were similar in age,
height, mass, BMI, and percentage of body fat. ABI for
both the right and left leg was higher in the CON subjects
compared with IC subjects (P  .001). IC subjects in-
cluded a higher proportion of current (P  .007) and
former smokers (P  .001) and a higher percentage of
subjects with diabetes (P .007), ischemic heart disease (P
 .001), and -blocker prescriptions (P  .001; Table I).
No changes in the results of this study were found when age
was controlled using multivariate statistical technique.
Gait. All gait temporal-spatial gait parameters were
significantly different between the IC and CON groups
except for single support ipsilateral limb time (P  .128;
Table IV. Peak angular velocity and acceleration values fo
matched for age and mass (N  53)
Variable* IC (n  28)
Ankle velocity (°/s)
Minimum –133.23  4.09
Maximum 191.02  7.41
Knee velocity (°/s)
Minimum –295.04  8.76
Maximum 350.59  11.56
Hip velocity (°/s)
Minimum –156.88  5.12
Maximum 108.18  4.22
Ankle acceleration (°/s2)
Minimum –4102.43  150.48
Maximum 3202.36  123.37
Knee acceleration (°/s2)
Minimum –5445.02  298.33
Maximum 3590.18  88.25
Hip acceleration (°/s2)
Minimum –2077.14  72.91
Maximum 1888.80  55.65
IC, Intermittent claudication; CON, control.
*Values are mean  standard error of the mean.
†P  .001 vs peripheral arterial disease-intermittent claudication.Table II). The IC subjects walked at a slower pace (20%)and took longer (7%) to complete a gait cycle, which was
characterized by a smaller (12%) stride length and lower
(7%) cadence. IC subjects spent longer (7%) completing a
stride, as a result of a longer (7%) ipsilateral leg contact and
flight time (7%). The IC subjects spent longer (5%) in the
single and double support (14%) stance phases. Significant
percentage differences of 7% to 20% between IC and CON
gait temporal-spatial parameters were found in this study.
Research has shown that the normal age effect on most
gait characteristics is in the magnitude of 4% to 9% for ages
60 to 80 years.24,25 Patients with diseases other than PAD,
such as Parkinson disease or multiple sclerosis, demonstrate
a greater percentage difference (11% to 40%) for gait tem-
poral-spatial parameters, but these neurologic diseases are
far more extreme then PAD.26 Compared with previous
PAD research, Gardner et al10 found significant differences
in gait characteristics such as stride length (13%), contact
time (2%), percentage of time spent in single support (4%),
percentage of time spent in double support (9%), and speed
(17%), which are similar to this current study.
Joint kinematic analysis determined significant between-
group differences for joint motion angles, with ankle plan-
tar flexion (20%), knee range of motion (6%), and hip
extension (23%) significantly reduced for IC compared
with CON subjects (Table III). Fig 2 presents graphic
representations of the significant range-of-motion differ-
ences for IC and CON subjects normalized (100 points)
over the gait cycle.
The IC subjects demonstrated significantly smaller
minimum and maximum joint angular velocities and accel-
erations for all variables compared with the CON subjects,
except for ankle joint angular acceleration maximum and
ermittent claudication subjects and healthy controls
CON (n  25) P
–161.63  7.47 .004
243.31  11.39 .001
–326.31  6.15 .005
393.23  7.92 .010
–178.66  5.95 .014
121.28  4.28 .018
–5446.83  267.84 .001†
3596.84  145.82 .059
–6254.65  211.05 .048
4008.82  90.63 .002
–2279.39  110.26 .139
2109.52  74.51 .035r inthip joint angular acceleration minimum (Table IV).
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(maximal walk distance) and physiologic responses (HRpeak,
VO2peak and VEpeak) were significantly greater for the
CON compared with the IC subjects (Table V). The 17
CON subjects who were unable to complete the treadmill
test complained only of general fatigue and not claudica-
tion pain.
Physical activity level. CON subjects took a signifi-
cantly greater number of steps and walked greater dis-
tances than the IC subjects over the 7-day post-test
period (Table VI).
DISCUSSION
Temporal-spatial gait parameter results indicated that
subjects with PAD-IC subjects compared with healthy con-
trols matched for age and mass spent a greater percentage
of time in gait support phases, took longer to complete a
stride, and had reduced stride length and walking speeds
during the gait cycle. These results confirm research indi-
cating that PAD-IC results in reduced temporal-spatial gait
parameters,9,10 but contradicts other research that showed
no significant gait changes.11-13 Research that has failed to
find a significant effect of PAD-IC on temporal-spatial
parameters compared with controls matched for age and
mass have used control subjects with comorbidities such as
coronary artery, diabetes, and lung disease,13 PAD-IC sub-
jects without intermittent claudication,12 PAD-IC subjects
that were engaged in regular medically supervised exercise
Table V. Walking performance and physiologic
responses of intermittent claudication subjects and





(n  25) P†
MWD (m) 271.8  34.8 941.4  70.2 .001†
HRpeak (beats/min) 111  3.5 140  3.5 .001
†
VO2peak (ml/[kg · min)] 18.3  1.3 34.5  1.7 .001
†
VEpeak (L/min) 39.1  3.8 63.7  5.3 .001
†
RERpeak 0.90  0.03 0.97  0.02 .050
IC, Intermittent claudication; CON, control; MWD, maximal walking dis-
tance; HR, heart rate; VO2, oxygen uptake; VE, ventilation; RER, respira-
tory exchange ratio.
*Values are mean  standard error of the mean.
†P .001 vs peripheral arterial disease-intermittent claudication.
Table VI. Seven-day physical activity levels of
intermittent claudication subjects and healthy controls
matched for age and mass (N  53)
Variable* IC (n  28) CON (n  25) P
Steps 29093  4008 47038  3524 .016
Distance (km) 16.9  2.3 30.4  2.3 .001†
Calories (kcal) 1148.8  169.9 1847.4  153.5 .023
*Values are mean  standard error of the mean.
†P  0.01 peripheral arterial disease-intermittent claudication.programs,11 and different techniques of gait analysis (eg,stop watches, which produce more human error).11-13
These factors may explain the failure of significant effect of
PAD-IC on temporal-spatial gait parameters in previous
studies and why the use of subjects without these factors, as
shown in the current study, demonstrates a significant
effect of PAD-IC on temporal-spatial gait parameters, gait
kinematics, walking performance, exercise capacity, and
physical activity level.
As shown in Fig 2, the kinematic descriptors of the
temporal-spatial gait parameters were reduced peak hip
extension (about 55% gait cycle), knee range of motion
(about 40% and 75% gait cycle), and peak ankle plantarflex-
ion (about 65% gait cycle). These reduced joint angular
displacements occurred around the time of preswing and
initial swing of the ipsilateral limb, indicating a shuffling
gait pattern much like the gait pattern evident in Parkinson
disease.26 The reduced joint angular displacements were
accompanied by reduced peak minimum and maximum
joint angular velocity and acceleration values clearly dem-
onstrating reduced lower limb mobility in IC compared
with CON subjects.
As indicated by the gait kinematics, mobility is reduced
in this population; therefore, it would be expected that
walking capacities and physical activity levels would also be
reduced compared with controls matched for age andmass.
The graded treadmill test results and 7-day pedometer
recordings confirmed this assumption. These findings rein-
force the view that individuals with PAD-IC are at greater
risk of future lower limb mobility loss and reduced capacity
to perform activities of daily living, resulting in decreased
quality of life and poorer health outcomes.8,27 It should be
noted that seven of the IC subjects were current smokers,
and this can cause a limitation of the walking performance
test, because subjects with PAD-IC have been shown to
have reduced pain-free walking distance, maximal walk
distance, and peak oxygen uptake compared with PAD-IC
former smokers.28-30 However, the aim of this study was to
examine the relationship between gait kinematics, walking
performance, exercise capacity, and physical activity level in
healthy controls and a typical population of PAD-IC pa-
tients, which will include smokers.
CONCLUSION
The results of this study demonstrated that individuals
with PAD-ICwalk with a shuffling gait pattern indicated by
reduced joint angular displacement, velocities, and acceler-
ations compared with healthy controls matched for age and
mass. The causes of this gait disturbance are likely multifac-
torial. Possible mechanisms include adaptation to the pain
association with lower limb ischemia, myopathy associated
with ischemia or diabetes, and cardiac impairment due to
associated coronary artery disease. The later is unlikely since
patients were excluded if they were thought to be unable to
tolerate a treadmill test.
Research has indicated that supervised exercise rehabil-
itation programs lead to significant improvement in walk-
ing performance, physical activity, and perceived quality of
life in PAD-IC individuals.31,32 Future research should
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tion programs on temporal-spatial gait parameters and the
gait kinematics of PAD-IC patients. This may provide a
better understanding of how PAD-IC affects gait as well as
provide new insights into the formulation of exercise reha-
bilitation treatment plans for PAD-IC.
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